Pfizer, BioNTech gain after saying they'll submit their COVID-19 vaccine to the FDA for emergency approval
The companies "believe in their capability to distribute the vaccine globally upon approval or authorization," they said.
Full Article
Pfizer, BioNTech gain after saying they'll submit their COVID-19 vaccine to the FDA for emergency approval
Business Insider
0 shares
1 views
You might like
Related news coverage
Moderna Seeks OK For Emergency Approval For COVID Vaccine, Now What?
Newsy
Watch VideoThe need for a COVID vaccine is greater than ever before as cases surge and hospitals are overwhelmed in much of the..
-
Moderna asking US, European regulators to greenlight COVID-19 vax
Mid-Day
-
Beware of COVID-19 scams as vaccine approaches FDA approval
SeattlePI.com
-
Coronavirus: UK expected to approve Pfizer/BioNTech vaccine this week, acquires 2mln extra doses of Moderna jab
Proactive Investors
-
CDC panel meets Tuesday to vote on COVID-19 vaccine priority
SeattlePI.com
Advertisement
More coverage
Pres. Trump Will Leave If Electoral College Seats Biden
Newsy
Watch VideoThe president spoke to reporters last night after holding a teleconference with U.S. military leaders stationed..